The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.
The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.
Results are available within a fortnight.
Online:
www.healthlinx.com.au
Phone: 03 9208 4200
Phone: 03 9208 4200
Related Products
Navinci Diagnostics Naveni CD8/MHC-I Atto647N proximity ligation assay (PLA) kit
The Naveni CD8/MHC-I Atto647N is an in situ proximity ligation assay kit for the detection of the...
Invent Biotechnologies Minute Single Cell Nuclei Kits
The Invent Biotechnologies Minute Single Cell Nuclei Kits use proprietary spin column-based...
MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution
MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces is a magnetic bead-based solution...
